Page last updated: 2024-11-06

floxuridine and Cystadenoma

floxuridine has been researched along with Cystadenoma in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Cystadenoma: A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
VillaSanta, U1

Other Studies

1 other study available for floxuridine and Cystadenoma

ArticleYear
Cyclophosphamide and floxuridine adjuvant chemotherapy for stage III and IV carcinoma of the ovary.
    Gynecologic oncology, 1980, Volume: 10, Issue:1

    Topics: Cyclophosphamide; Cystadenocarcinoma; Cystadenoma; Drug Therapy, Combination; Female; Floxuridine; H

1980